...
【24h】

Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.

机译:副肿瘤和非副肿瘤神经病患者的抗SOX1抗体。

获取原文
获取原文并翻译 | 示例
           

摘要

Anti-SOX1 antibodies have been described to be positive in patients with paraneoplastic Lambert-Eaton myasthenic syndrome and, in a lower amount, in patients with anti-Hu positive paraneoplastic neurological syndromes, and with SCLC alone, respectively. We found 5/32 patients with paraneoplastic neuropathy and, surprisingly, 4/22 patients with neuropathy of unknown origin positive for anti-SOX1 antibodies, whereas no patient with inflammatory neuropathy and no healthy controls showed any reactivity (p=0.007). All patients with neuropathy of unknown origin where followed up for four years without diagnosis of a tumour so far. Anti-SOX1 antibodies are associated with paraneoplastic neuropathies and may define another group of non-paraneoplastic, immune-mediated neuropathies.
机译:抗SOX1抗体已被描述为在副肿瘤性Lambert-Eaton重症肌无力综合症患者中呈阳性,而在抗Hu副肿瘤性神经综合症综合症患者中和单独在SCLC中呈阳性。我们发现5/32患有副肿瘤性神经病的患者,令人惊讶地是,有4/22患有未知来源的神经病的患者抗SOX1抗体呈阳性,而没有炎症性神经病和健康对照的患者没有任何反应(p = 0.007)。所有来历不明的神经病变患者均已随访四年,迄今未诊断出肿瘤。抗SOX1抗体与副肿瘤性神经病有关,可能定义了另一组非副肿瘤性免疫介导的神经病。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号